Cargando...
Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
INTRODUCTION: Mucopolysaccharidosis Type II (MPS II; Hunter syndrome) is an X- linked lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS). IDS deficiency leads to primary accumulation of dermatan sulfate (DS) and heparan sulfate (HS). MPS II is both multi-systemic and pr...
Guardado en:
| Publicado en: | Expert Opin Orphan Drugs |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693349/ https://ncbi.nlm.nih.gov/pubmed/29158997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2017.1296761 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|